Mechanisms of atherosclerosis: role of LDL oxidation.
Reaven
P D
PD
Department of Medicine, University of California, San Diego, La Jolla 92093, USA.
D000818:Animals; D000975:Antioxidants / Q000494:pharmacology / Q000627:therapeutic use; D001161:Arteriosclerosis / Q000378:metabolism* / Q000503:physiopathology* / Q000517:prevention & control; D002986:Clinical Trials as Topic; D015331:Cohort Studies; D006801:Humans; D008077:Lipoproteins, LDL / Q000097:blood*; D008955:Models, Cardiovascular; D017202:Myocardial Ischemia / Q000188:drug therapy; D010084:Oxidation-Reduction; D017382:Reactive Oxygen Species / Q000494:pharmacology / Q000627:therapeutic use
D000975:Antioxidants; D008077:Lipoproteins, LDL; D017382:Reactive Oxygen Species